Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

52.80 -5.98 (-10.17%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 10, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	9,434,590
Open	53.94
Bid (Size)	52.70 (100)
Ask (Size)	52.77 (400)
Prev. Close	58.78
Today's Range	50.66 - 55.40
52wk Range	30.04 - 78.48
Shares Outstanding	78,935,098
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Monster Stocks to Hold for the Next 10 Years ↗

Today 21:20 EDT

They're names worth holding for far longer, but the coming decade could prove particularly fruitful for these companies.

Via The Motley Fool

This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday ↗

Today 15:43 EDT

Current shareholders were thrown an unexpected curveball that they actually should have been expecting.

Via The Motley Fool

Performance

YTD	-1.8%	-1.8%
1 Month	+6.2%	+6.2%
3 Month	-7.4%	-7.4%
6 Month	-1.7%	-1.7%
1 Year	+21.8%	+21.8%

More News

Why Is CRSP Stock Falling Pre-Market Today? ↗

Today 7:51 EDT

Via Stocktwits

RIVN Stock Gains 4% Pre-Market After TD Cowen Upgrade: Analyst Sees Strong Demand For Upcoming R2 Models ↗

Today 7:39 EDT

Via Stocktwits

Forget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of ↗

March 04, 2026

Via The Motley Fool

Is CRISPR Therapeutics Stock Too Risky to Buy Right Now? ↗

March 02, 2026

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

March 01, 2026

Via The Motley Fool

Is CRISPR Therapeutics Stock Going to $0, or Will the Hype Pay Off? ↗

February 20, 2026

Via The Motley Fool

The Gene‑Therapy Breakthrough Story You'll Be Mad You Ignored at These Prices ↗

February 20, 2026

Via The Motley Fool

2 Innovative Biotech Stocks That May Climb 58% and 200%, According to Wall Street ↗

February 19, 2026

Via The Motley Fool

CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows ↗

February 19, 2026

Via MarketBeat

Should You Buy Shares of CRISPR Therapeutics in February? ↗

February 18, 2026

Via The Motley Fool

The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026 ↗

February 13, 2026

Via The Motley Fool

Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss) ↗

February 13, 2026

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

January 30, 2026

Via The Motley Fool

Forget AI Stocks: This Biotech Could Cure What AI Can't Touch ↗

January 29, 2026

Via The Motley Fool

Nasdaq, S&P 500 Futures Climb Ahead Of Apple Earnings: Why META, TSLA, MP, CRML, SER Are On Traders' Radar Today ↗

January 29, 2026

Via Stocktwits

Cathie Wood's Favorite Biotech Stock Is Under Pressure Amid Insider Sales And Slow Revenue Growth: Momentum Score Drops ↗

January 27, 2026

Via Benzinga

2 Biotech Stocks That Could Soar This Year ↗

January 12, 2026

Via The Motley Fool

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

Via MarketMinute

These 2 Healthcare Stocks Beat the Market in 2025. Should You Buy Them in 2026? ↗

December 26, 2025

Via The Motley Fool

The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy

December 24, 2025

Via PredictStreet

Is CRISPR Therapeutics Stock Yesterday's News? ↗

December 24, 2025

Via The Motley Fool

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗

December 23, 2025

Via The Motley Fool

Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? ↗

December 19, 2025

Via The Motley Fool

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?

Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.

What exchange does CRISPR Therapeutics AG - Common Shares trade on?

CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?

The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market

What is the current price of CRISPR Therapeutics AG - Common Shares?

The current price of CRISPR Therapeutics AG - Common Shares is 52.80

When was CRISPR Therapeutics AG - Common Shares last traded?

The last trade of CRISPR Therapeutics AG - Common Shares was at 03/10/26 04:00 PM ET

What is the market capitalization of CRISPR Therapeutics AG - Common Shares?

The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.17B

How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?

CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.